SYMPTOMATIC THROMBOCYTOPATHY

Аннотация

Symptomatic thrombocytopathy refers to a group of disorders characterized by abnormal platelet function, leading to bleeding and thrombotic complications. Unlike thrombocytopenia, where platelet count is low, thrombocytopathy involves normal or elevated platelet counts with impaired function. This condition can be congenital or acquired, with various underlying causes including genetic mutations, autoimmune diseases, and drug-induced effects. Patients often present with mucocutaneous bleeding, easy bruising, and, paradoxically, thrombotic events such as deep vein thrombosis or pulmonary embolism. Diagnosis involves platelet function assays, bleeding time tests, and genetic screening. Management strategies are tailored to the underlying etiology and may include platelet transfusions, antifibrinolytic agents, or immunosuppressive therapy. Early recognition and https://scientific-jl.com/luch/ 2 8 1 Часть-47_ Том-2_ июнь-2025 appropriate treatment are crucial to prevent severe hemorrhagic or thrombotic events. Key Terms: Platelet dysfunction, bleeding disorders, thrombotic events, congenital thrombocytopathy acquired thrombocytopathy, platelet punction assays, antifibrinolytic therapy, immunosuppressive treatment, thrombocytopathy diagnosis, hemostatic abnormalities. 1. Introduction Platelets play a crucial role in hemostasis, and their dysfunction can lead to significant bleeding or thrombotic complications. Symptomatic thrombocytopathy encompasses disorders where platelets are present in normal or elevated numbers but exhibit impaired function. This condition can be classified into congenital and acquired forms, each with distinct etiologies and clinical presentations. 2. Classification and Etiology 2.1 Congenital Thrombocytopathy Congenital thrombocytopathies are rare inherited disorders resulting from genetic mutations affecting platelet function. These include defects in platelet adhesion, aggregation, secretion, and signal transduction pathways. Examples include Bernard-Soulier syndrome, Glanzmann thrombasthenia, and storage pool disorders.pmc.ncbi.nlm.nih.gov 2.2 Acquired Thrombocytopathy Acquired thrombocytopathies can result from various factors, including: https://scientific-jl.com/luch/ 2 8 2 Часть-47_ Том-2_ июнь-2025 Medications: Aspirin, clopidogrel, and other antiplatelet drugs can impair platelet function. Autoimmune Diseases: Conditions like systemic lupus erythematosus can lead to the development of autoantibodies against platelet receptors. Uremia: Chronic kidney disease can result in uremic toxins that impair platelet function.haematologica.org+1pubmed.ncbi.nlm.nih.gov+1 Liver Disease: Severe liver dysfunction can lead to impaired synthesis of clotting factors and platelet dysfunction. 3. Pathophysiology The pathophysiology of symptomatic thrombocytopathy involves defects in various platelet functions: Adhesion: Defective interaction between platelets and the subendothelial matrix. Aggregation: Impaired platelet-to-platelet interaction, leading to inadequate clot formation. Secretion: Defective release of granule contents, essential for platelet activation and stabilization of the hemostatic plug. Signal Transduction: Altered intracellular signaling pathways affecting platelet activation and function. 4. Clinical Manifestations Patients with symptomatic thrombocytopathy may present with: Mucocutaneous Bleeding: Easy bruising, epistaxis, gum bleeding, and menorrhagia.pmc.ncbi.nlm.nih.gov https://scientific-jl.com/luch/ 2 8 3 Часть-47_ Том-2_ июнь-2025 Post-Surgical Bleeding: Excessive bleeding following minor surgical procedures. Thrombotic Events: Paradoxical occurrence of thrombosis despite bleeding tendencies. Family History: A positive family history may suggest a congenital etiology.haematologica.org 5. Diagnostic Approach Diagnosis of symptomatic thrombocytopathy involves: Platelet Function Tests: Assessing platelet aggregation, secretion, and adhesion. Bleeding Time: Evaluating the time taken for bleeding to stop after a standardized incision. Genetic Testing: Identifying mutations associated with congenital disorders. Platelet Count and Morphology: Evaluating platelet number and size. 6. Management Strategies Management depends on the underlying etiology and may include: Platelet Transfusions: Used in cases of severe bleeding.pubmed.ncbi.nlm.nih.gov Antifibrinolytic Agents: Such as tranexamic acid, to prevent premature clot breakdown. Immunosuppressive Therapy: In cases of autoimmune-induced thrombocytopathy. https://scientific-jl.com/luch/ 2 8 4 Часть-47_ Том-2_ июнь-2025 Avoidance of Antiplatelet Medications: In acquired cases due to drug-induced effects. Gene Therapy: Emerging treatment for certain congenital disorders.ncbi.nlm.nih.gov+1pmc.ncbi.nlm.nih.gov+1 7. Prognosis and Follow-Up The prognosis varies depending on the severity of the disorder and the effectiveness of treatment. Regular follow-up is essential to monitor for bleeding or thrombotic complications and to adjust tre